Delacruz v. Tanimura & Antle, Inc.

District Court, N.D. California·Decided July 25, 2024·No. 5:23-cv-03034·Unknown

Opinion

DANIEL DELACRUZ, Case No. 23-cv-03034-VKD

Plaintiff, ORDER GRANTING DEFENDANT v. QUIRARTE'S MOTION TO DISMISS SECOND AMENDED COMPLAINT TANIMURA & ANTLE, INC., et al., Re: Dkt. No. 56 Defendants.

Plaintiff Daniel Delacruz, who is representing himself, filed this action against defendants Tanimura & Antle, Inc. (“TAI”), Mike Antle, and Carmen Ponce (collectively, “TAI defendants”) and Claudia Quirarte, asserting, among other things, unlawful disability discrimination under the Americans with Disabilities Act (“ADA”). Dkt. No. 1. Since the filing of this lawsuit, the Court has granted defendants’ respective motions to dismiss Mr. Delacruz’s claims (Dkt. Nos. 28, 29, 52, 53), and Mr. Delacruz has amended his complaint twice, asserting federal claims only against Ms. Quirarte (Dkt. Nos. 34, 55). In its most recent order, the Court dismissed the federal claims asserted against Ms. Quirarte, with leave to amend only as to Mr. Delacruz’s claim under the Rehabilitation Act. Dkt. No. 52. The Court declined to exercise supplemental jurisdiction over any of Mr. Delacruz’s state law claims, unless and until he pleads a viable federal claim for relief. Id. Ms. Quirarte now moves pursuant to Rule 12(b)(6) to dismiss Mr. Delacruz’s second amended complaint (“SAC”).1 Dkt. Nos. 56, 61. Mr. Delacruz opposes the motion. Dkt. No. 59. The Court deemed the motion suitable for determination without oral argument. See Civil L.R. 7- 1(b); Dkt. No. 63. Upon consideration of the moving and responding papers, the Court grants Ms. Quirarte’s motion to dismiss the Rehabilitation Act claim without leave to amend.2 According to the SAC, Mr. Delacruz was diagnosed in 1992 with Fabry Disease, a rare hereditary enzyme deficiency disorder, for which he receives enzyme replacement therapy (“ERT”) “on a regular basis to prevent chronic organ failure and death.” Dkt. No. 55 ¶¶ 13, 15. Ms. Quirarte is identified as a registered nurse employed by Central Coast Nephrology, the medical facility where Mr. Delacruz received ERT. Id. ¶¶ 6, 23, 37. Defendant TAI is a produce company that employed Mr. Delacruz from about April 1988 to July 1996. See Dkt. No. 55 ¶¶ 7, 13 & Ex. 1 at ECF 2. Defendant Mike Antle is identified as an “owner, employee, and a Vice President” of TAI. Dkt. No. 55 ¶ 8. Defendant Carmen Ponce is identified as TAI’s “Vice President of Human Resources and Assistant General Counsel[.]” Id. ¶ 9. In 1998, Mr. Delacruz sued TAI and Mr. Antle in state court for race discrimination. Id. ¶ 14. The parties resolved the matter and entered into a settlement agreement. Id. & Ex. 1. According to Mr. Delacruz, as part of that settlement, the TAI defendants agreed not to harass him. Id. Mr. Delacruz claims that the TAI defendants have breached that agreement by, among other things, “disseminat[ing] to various people, including Claudia Quirarte, falsehoods including that [he] ‘filed a lot of complaints that went nowhere’ and that [he] is ‘not disabled.’” Dkt. No. 55 ¶ 29. Mr. Delacruz alleges that his “hereditary disorder was well known to [Mr.] Antle and [Ms.] Ponce.” Id. ¶ 19. For example, he says that on one occasion during his employment with TAI, Rick Antle (identified as TAI’s president, now deceased) was in a break room eating one of TAI’s salad products with heavy dressing. See id. ¶ 21. When Mr. Delacruz commented, “[B]e careful, that stuff can give you a heart attack,” Rick Antle reportedly replied, “[Y]ou’re the one that needs to worry about that stuff!” Dkt. No. 34 ¶¶ 21, 22. According to Mr. Delacruz, Rick Antle’s response was a gloating reference to his enzyme deficiency disorder and an indication that Rick Antle believed that he would outlive Mr. Delacruz. Id. ¶ 22. The SAC further alleges that years later, in 2018, Rick Antle passed away. Id. ¶ 22. In 2019, during one of Mr. Delacruz’s ERT procedures, Mr. Delacruz “recited Rick Antle’s malevolent gloat made towards [Mr. Delacruz] and the irony of Rick Antle’s death[.]” Id. ¶ 23. Ms. Quirarte allegedly overheard Mr. Delacruz’s comment and repeated it to defendants Mike Antle and Ms. Ponce. Id. Mr. Delacruz alleges that this “further enraged the visceral contempt that [Mr.] Antle and [Ms.] Ponce have towards [him]” and caused them “to interfere with [Mr. Delacruz]’s health services to fulfill the death threats that [he] had been receiving from TAI’s employees[.]” Id. ¶ 24. Mr. Delacruz alleges that, in addition to telling Ms. Quirarte falsehoods about him, Mr. Antle and Ms. Ponce “solicited [Ms.] Quirarte to obtain a sample of [Mr. Delacruz]’s blood for nefarious purposes,” e.g., “for analysis to fraudulently dispute [Mr. Delacruz]’s disability of Fabry Disease.” Id. ¶ 29. Mr. Antle and Ms. Ponce allegedly “also solicited [Ms.] Quirarte to interfere with [Mr. Delacruz]’s ERT procedures by deceitfully leaving out the medication from [his] [intravenous] IV bags,” “caus[ing] [Mr. Delacruz]’s various organ functions to deteriorate over time including his central nervous system resulting in tremors to his hands and loss of dexterity.” Id. ¶ 32. The SAC alleges “[i]n the alternative,” that Mr. Antle’s and Ms. Ponce’s “reckless dissemination of falsehoods . . . motivated [Ms.] Quirarte to interfere sua sponte with [Mr. Delacruz]’s ERT medication” and “to obtain a sample of [Mr. Delacruz]’s blood and deliver it to [Mr.] Antle and [Ms.] Ponce sua sponte to dispute [Mr. Delacruz]’s disability.” Id. ¶ 33. Mr. Delacruz says that during one of his medical procedures, in which Ms. Quirarte removed an IV needle from his arm, she “deliberately released the pressure from [his] vein over the injection site and maneuvered the needle out in an exaggerated arching path causing the needle to drip a stream of blood onto the medical pillow” that was supporting his arm. Id. ¶ 39. Ms. Quirarte reportedly never did this before. Id. ¶ 40. Rather than comply with protocols requiring that the pillow in plain view of [Mr. Delacruz],” Ms. Quirarte reportedly “took the disposable pillow case stained with [Mr. Delacruz]’s blood back to her work area located in a small room about twenty feet opposite to where [Mr. Delacruz] was seated and placed it on a shelf.” Id. ¶ 41. According to the complaint, Ms. Quirarte previously “never deviated from the proper disposal protocol of used disposable medical pillow cases.” Id. The SAC further alleges that Ms. Quirarte violated Mr. Delacruz’s privacy rights by giving the blood-stained pillowcase “to [Mr.] Antle and [Ms.] Ponce to use for their nefarious purpose of fraudulently disputing [Mr. Delacruz]’s disability.” Id. ¶ 42. Additionally, the SAC alleges that “[Ms.] Quirarte would harass [Mr. Delacruz] with contemptuous and snide remarks including ‘[Y]ou don’t look disabled.’” Id. ¶ 37. During an April 2021 ERT procedure, Ms. Quirarte reportedly “contemptuously star[ed]” at Mr. Delacruz and “snidely remarked . . . ‘Look, he’s going to start complaining!’” Id. ¶ 38. Mr. Delacruz says that “[w]henever possible, [he] would change his schedule for his ERT procedures so that a different nurse would prepare his medication in an attempt to avoid [Ms.] Quirarte.” Id. Ms. Quirarte, however, allegedly “would also adjust her work schedule to remain as [Mr. Delacruz]’s nurse.” Id. The SAC further alleges that after Mr. Antle and Ms. Ponce “disseminated to [Ms.] Quirarte their fraudulent dispute” regarding his disability, and Ms. Quirarte made a “snide comment to [Mr. Delacruz] that he did not look disabled,” Ms. Quirarte “deceitfully left out the ERT medication from [his] IV bags,” “caus[ing] [his] various organ functions to deteriorate over time including his central nervous system resulting in tremors to his hands and loss of dexterity.” Id. ¶ 43. Additionally, Mr. Delacruz alleges that around June 26, 2019, Ms. Quirarte prepared his IV bag “that appeared abnormal and foamy, which had never occurred in over 600 ERT treatments that [he] has received over the past 25 years.” Id. ¶ 44. But when Mr. Delacruz inquired ab

Free access — add to your briefcase to read the full text and ask questions with AI

Delacruz v. Tanimura & Antle, Inc., (N.D. Cal. 2024).

Delacruz v. Tanimura & Antle, Inc. (Delacruz v. Tanimura & Antle, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Haines v. Kerner
404 U.S. 519 (Supreme Court, 1972)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Fayer v. Vaughn
649 F.3d 1061 (Ninth Circuit, 2011)
Lee v. City Of Los Angeles
250 F.3d 668 (Ninth Circuit, 2001)
In Re Gilead Sciences Securities Litigation
536 F.3d 1049 (Ninth Circuit, 2008)
Coto Settlement v. Eisenberg
593 F.3d 1031 (Ninth Circuit, 2010)
Leadsinger, Inc. v. BMG Music Publishing
512 F.3d 522 (Ninth Circuit, 2008)
Becker v. Oregon
170 F. Supp. 2d 1061 (D. Oregon, 2001)
Kaufmann v. Holder
759 F.3d 6 (First Circuit, 2014)
Karim Khoja v. Orexigen Therapeutics, Inc.
899 F.3d 988 (Ninth Circuit, 2018)
Lopez v. Smith
203 F.3d 1122 (Ninth Circuit, 2000)
Navarro v. Block
250 F.3d 729 (Ninth Circuit, 2001)